Financhill
Back

Bone Biologics Quote, Financials, Valuation and Earnings

Bone Biologics Price Quote

$1.32
+0.14 (+11.86%)
(Updated: November 14, 2024 at 5:55 PM ET)

Bone Biologics Key Stats

Sell
7
Bone Biologics (BBLG) is a Sell

Day range:
$1.14 - $1.21
52-week range:
$0.80 - $10.56
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.74%

Volume:
87.3K
Avg. volume:
311.8K
1-year change:
-70.5%
Market cap:
$2.2M
Revenue:
$0
EPS:
$-9.76

How Much Does Bone Biologics Make?

Data Unavailable

Is Bone Biologics Growing As A Company?

Data Unavailable

Bone Biologics Stock Price Performance

  • Did Bone Biologics Stock Go Up Last Month?
    Bone Biologics share price went down by -29.34% last month
  • Did BBLG's Share Price Rise Over The Last Year?
    BBLG share price fell by -70.5% over the past 1 year

What Is Bone Biologics 52-Week High & Low?

Bone Biologics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Bone Biologics?

  • How Much Debt Does Bone Biologics Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Bone Biologics Have?
    Cash and short term investments quarterly total is $2.3M
  • What Is Bone Biologics’s Book Value Per Share?
    Book value per share is 2.21

Is Bone Biologics Cash Flow Positive?

  • What Is BBLG Cash Flow From Operations?
    Cash flow from operations (TTM) is -$6.8M
  • What Is Bone Biologics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $2.1M
  • What Is Bone Biologics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Bone Biologics Return On Invested Capital

Data Unavailable

Bone Biologics Earnings Date & Stock Price

Bone Biologics Competitors

  • Who Are Bone Biologics's Competitors?
    Below is a list of companies who compete with Bone Biologics or are related in some way:
    • Dermata Therapeutics Inc (DRMA)
    • iBio Inc (IBIO)
    • Johnson & Johnson (JNJ)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)

Bone Biologics Dividend Yield

Bone Biologics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 51.8%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 16.75
Upside from Last Price: 1319.49%

Major Shareholders

  • How many BBLG shares are owned by institutional investors?
    116.1K BBLG shares are owned by institutional investors
  • How many BBLG shares are owned by insiders?
    0 BBLG shares are owned by insiders